Match!
David Jérémie Birnbaum
Aix-Marseille University
33Publications
6H-index
247Citations
Publications 33
Newest
#1Théophile Guilbaud (AMU: Aix-Marseille University)H-Index: 2
#2David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
Last.Laura Beyer Berjot (AMU: Aix-Marseille University)
view all 0 authors...
Background The laparoscopic approach is widely accepted as the procedure of choice for abdominal surgery. However, laparoscopic liver resection (LLR) has advanced slowly due to the significant learning curve (LC), and only few publications have dealt with advanced training in LLR.
#2David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
Last.Laura Beyer-Berjot (AMU: Aix-Marseille University)H-Index: 9
view all 4 authors...
Purpose. Anastomotic leak is the main complication after low colorectal anastomosis. Defunctioning ileostomy is therefore recommended, which carries its own morbidity. The aim of this study was to ...
#1Théophile Guilbaud (AMU: Aix-Marseille University)H-Index: 2
#2P. Berbis (AMU: Aix-Marseille University)H-Index: 4
Last.David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
view all 3 authors...
#1Théophile Guilbaud (AMU: Aix-Marseille University)H-Index: 2
#2David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
Last.Vincent Moutardier (AMU: Aix-Marseille University)H-Index: 29
view all 8 authors...
Background Postoperative pancreatic fistula and pancreas-specific complications have a significant influence on patient management and outcomes after pancreatoduodenectomy. The aim of the study was to assess the value of serum C-reactive protein on the postoperative day 1 as early predictor of pancreatic fistula and pancreas-specific complications.
#1David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
#2François Bertucci (AMU: Aix-Marseille University)H-Index: 28
Last.Emilie Mamessier (AMU: Aix-Marseille University)H-Index: 20
view all 5 authors...
Abstract Clinico-pathological factors fail to consistently predict the outcome after pancreatic resection for pancreatic ductal adenocarcinoma (PDAC). PDACs show a high level of inter- and intra- tumor genetic heterogeneity. A molecular classification should help sort patients into less heterogeneous and more appropriate groups regarding the metastatic risk and the therapeutic response, with the consequences of better predicting evolution and better orienting the treatment. PDAC can be classifie...
#1David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
#2Pascal Finetti (AMU: Aix-Marseille University)H-Index: 42
Last.François Bertucci (AMU: Aix-Marseille University)H-Index: 28
view all 5 authors...
Four molecular classifications of pancreatic ductal adenocarcinoma (PDAC), biologically and clinically relevant and based on gene expression profiles, were established in the recent years, including the Collisson’s, Moffitt’s (“tumor” and “stroma” classifications), and Bailey’s classifications. The aim of this study was to validate the prognostic value of the Moffitt’s classifications and to compare the Collisson’s, Moffitt’s, and Bailey’s classifications in a large series of samples. We collect...
#1Théophile Guilbaud (AMU: Aix-Marseille University)H-Index: 2
#2David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
Last.Vincent Moutardier (AMU: Aix-Marseille University)H-Index: 29
view all 9 authors...
Background Delayed gastric emptying (DGE) is the most frequent pancreatic specific complication (PSC) after pancreaticoduodenectomy (PD). Several gastric decompression systems exist to manage DGE. Patients with a pancreatic tumor require prolonged nutrition; however, controversies exist concerning nutrition protocol after PD. The aim of the study was to assess the safety and efficacy of nasogastric (NG), gastrostomy (GT), and gastrojejunostomy (GJ) tubes with different feeding systems on postope...
#1David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
#2Pascal Finetti (AMU: Aix-Marseille University)H-Index: 42
Last.Emilie Mamessier (AMU: Aix-Marseille University)H-Index: 20
view all 11 authors...
Abstract Background Pancreatic carcinoma is one of the most lethal human cancers. In patients with resectable tumors, surgery followed by adjuvant chemotherapy is the only curative treatment. However, the 5-year survival is 20%. Because of a strong metastatic propensity, neoadjuvant chemotherapy is being tested in randomized clinical trials. In this context, improving the selection of patients for immediate surgery or neoadjuvant chemotherapy is crucial, and high-throughput molecular analyses ma...
#1Théophile Guilbaud (AMU: Aix-Marseille University)H-Index: 2
#2David Jérémie Birnbaum (AMU: Aix-Marseille University)H-Index: 6
Last.Vincent Moutardier (AMU: Aix-Marseille University)H-Index: 29
view all 5 authors...
123